[Oncology patients in a pediatric intensive care unit--a 7-year experience].
BACKGROUND
As a result of improved therapeutic and diagnostic modalities the survival rate of children with neoplastic disease has increased dramatically. The consequences of these scientific advances have led to increased malignancy-related critical complications requiring the expertise of intensive care practitioners.


METHODS
From all children admitted to the pediatric intensive care unit (PICU) of the Martin-Luther University Halle those with hematologic-oncologic condition were evaluated.


RESULTS
From 4068 PICU admissions 196 (4.8%) oncologic patients were identified. Most of them were admitted for postoperative care, monitoring or intervention. 24 patients were admitted because of severe disease or treatment related complications. 14 out of 24 (58%) patients died on PICU. Mortality was significant higher in a subgroup requiring mechanical ventilation or suffering from sepsis. All patients but two with multi-organ system failure (> or = 2 organs) died.


CONCLUSIONS
Children with neoplastic disease can benefit from pediatric intensive care unit (PICU) support. Successful treatment of life-threatening complications requires a close cooperation of pediatric oncology and PICU. Further studies are necessary to improve therapeutic strategies in oncology patients requiring PICU admission.
Haase
R
R
Universitätsklinik und Poliklinik für Kinder und Jugendmedizin, Zentrum für Kinderheilkunde, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale. roland.hasse@medizin.uni-halle.de
Mathony
U
U
Lieser
U
U
Nagel
F
F
Sitka
U
U
Burdach
S
S
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D005858:Germany; D006801:Humans; D007223:Infant; D015278:Intensive Care Units, Pediatric / Q000706:statistics & numerical data*; D007938:Leukemia / Q000150:complications / Q000401:mortality / Q000628:therapy; D008297:Male; D009102:Multiple Organ Failure / Q000175:diagnosis / Q000209:etiology; D009369:Neoplasms / Q000150:complications / Q000401:mortality / Q000628:therapy*; D012307:Risk Factors; D012737:Sex Factors; D016896:Treatment Outcome